Balance Sheet for Eagle Pharmaceuticals Inc. (EGRX)

$ 47.49   1.02 (+2.19%) Volume: 146.21k 4:00 PM EDT Oct 22, 2020
After Hours:  $ 47.49 0.00 (0.00%) Volume: 2.75k 4:10 PM EDT Oct 22, 2020
Statement: View:
Assets [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Cash and Equivalents 109,775 78,791 114,657 52,820 79,083
Restrictable Cash - - - - -
Marketable Securities - - - - -
Accounts Receivable 48,004 66,486 53,821 42,194 26,267
Loans Receivable - - - - -
Other Receivables - - - - 392
Receivables 48,004 66,486 53,821 42,194 26,267
Inventories, Raw Materials 2,460 6,303 2,489 1,131 8,687
Inventories, Work in Progress 3,243 1,776 931 900 6,044
Inventories, Purchased Components - - - - -
Inventories, Finished Goods 863 225 1,698 708 311
Inventories, Other 6,566 8,304 5,118 2,739 15,042
Inventories, Adjustments & Allowances - - - - -
Inventories 6,566 8,304 5,118 2,739 15,042
Prepaid Expenses 13,659 10,129 14,540 11,002 1,645
Current Deferred Income Taxes - - - - -
Other Current Assets 1,445 134 561 355 220
Total Current Assets 179,449 163,844 188,697 109,110 122,257
Land and Improvements - - - - -
Buildings and Improvement 1,144 1,129 4,596 1,129 978
Machinery, Furniture and Equipment 5,377 4,615 4,662 3,693 2,092
Construction in Progress - - - - -
Fixed Assets, Other - - - - -
Fixed Assets, Total 6,521 5,744 9,258 4,822 3,070
Gross Fixed Assets 6,521 5,744 9,258 4,822 3,070
Accumulated Depreciation (4,319) (3,347) (2,438) (1,506) (865)
Net Fixed Assets 2,202 2,397 6,820 3,316 2,205
Intangibles 15,583 18,103 23,322 33,372 -
Cost in Excess 39,743 39,743 39,743 39,743 -
Non-Current Deferred Income Taxes 13,669 13,822 11,354 28,643 -
Other Non-Current Assets 3,908 694 124 136 143
Total Non-Current Assets 75,105 74,759 81,363 105,210 2,348
Total Assets 254,554 238,603 270,060 214,320 124,605
Liabilities [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Accounts Payable 11,466 17,056 16,291 23,784 12,882
Short Term Debt 5,000 6,250 4,875 - -
Notes Payable - - - - -
Accrued Expenses 22,357 16,380 11,081 16,169 14,571
Accrued Liabilities 22,357 16,380 11,081 16,169 14,571
Deferred Revenues - - - - 6,000
Current Deferred Income Taxes 152 (2,468) 17,289 (30,116) -
Other Current Liabilities - - 15,055 791 334
Total Current Liabilities 38,823 39,686 47,302 40,965 34,262
Long Term Debt 33,557 38,155 42,905 - -
Deferred Income Tax - - - - -
Other Non-Current Liabilities - - 709 22,129 -
Minority Interest - - - - -
Capital Lease Obligations 3,000 - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 36,557 38,155 43,614 22,129 -
Total Liabilities 75,380 77,841 90,916 63,094 34,262
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 179,174 160,762 179,144 151,226 90,343
Common Par 17 17 16 16 15
Additional Paid in Capital 278,518 256,458 233,639 213,872 197,440
Cumulative Translation Adjustments - - - - -
Retained Earnings 72,500 58,187 26,284 (25,659) (107,112)
Treasury Stock 171,861 153,900 80,795 37,003 -
Other Equity Adjustments - - - - -
Total Capitalization 212,731 198,917 222,049 151,226 90,343
Total Equity 179,174 160,762 179,144 151,226 90,343
Total Liabilities & Shareholder's Equity 254,554 238,603 270,060 214,320 124,605
Cash Flow 14,313 31,905 51,943 81,456 2,572
Working Capital 140,626 124,158 141,395 68,145 87,995
Free Cash Flow 55,209 52,251 53,733 32,517 (11,599)
Invested Capital 212,731 198,917 222,049 151,226 90,343
Shares Outstanding - Common Class Only 13,630 13,914 14,848 15,324 15,636
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 13,630 13,914 14,848 15,324 15,636
Total Common Shares Outstanding 13,630 13,914 14,848 15,324 15,636
Treasury Shares 2,908 2,590 1,242 567 -
Basic Weighted Shares Outstanding 13,755 14,769 15,103 15,534 15,250
Diluted Weighted Shares Outstanding 14,139 15,279 15,908 16,434 16,254